Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (DK52025, GM60905)
  • Assisi Foundation of Memphis
  • American Lebanese Syrian Associated Charities (ALSAC)

This publication has 37 references indexed in Scilit: